Balanced Pharma develops buffered local anesthetics designed to reduce pain during dental injections and improve the reliability of anesthesia in inflamed tissues. By addressing the high failure rate of current anesthetic methods, their technology aims to enhance patient comfort and streamline dental procedures.
Funding
$6.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current dental anesthetics contain an acid preservative, leading to pain during injection and a delayed anesthetic effect. This results in patient discomfort, wasted time for dentists, and a significant failure rate in achieving effective anesthesia, particularly in inflamed tissues.
Solution
Balanced Pharma is developing buffered local anesthetics, including Libracaine (BPI-001), designed to reduce pain during dental injections, provide faster-acting anesthesia, and improve reliability, especially in inflamed tissues. Their patented dual-chamber cartridge technology allows for an acid-free formulation of common anesthetics like lidocaine and articaine with epinephrine, delivered in a standard dental cartridge. By removing the acid preservative, Balanced Pharma aims to enhance patient comfort and streamline dental procedures, offering a seamless replacement for existing products without requiring new equipment or training. The company's lead candidate, BPI-001, is intended for the dental market, while BPI-004 (Enduracaine) is a non-opioid, single-dose injectable local analgesic that provides up to three days of pain relief following surgical procedures.
Target Audience
The primary target audience includes dentists and dental hygienists seeking improved local anesthetics that offer less pain, faster action, and increased reliability, as well as surgeons seeking non-opioid pain relief options.
Features
- Buffered lidocaine/epinephrine and articaine/epinephrine formulations
- Acid-free formulations to reduce injection pain and speed onset
- Patented dual-chamber cartridge technology
- Standard dental cartridge format for seamless integration
- BPI-001 (Libracaine) designed for less painful, faster-acting, and more reliable dental anesthesia
- BPI-004 (Enduracaine) is a non-opioid, single-dose injectable local analgesic that provides up to three days of pain relief following surgical procedures.